HUMANA INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HUMANA INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $129.66B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $117.76B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $106.37B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $92.87B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $83.06B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $77.16B | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | $16.30B | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $16.24B | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $16.25B | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $16.11B | Feb 20, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $53.36B | Feb 16, 2018 |
| FY2017 | Dec 31, 2016 | $53.99B | Feb 16, 2018 |
| FY2017 | Dec 31, 2015 | $53.82B | Feb 16, 2018 |
| FY2016 | Dec 31, 2014 | $48.12B | Feb 17, 2017 |
| FY2015 | Dec 31, 2013 | $40.94B | Feb 18, 2016 |
| FY2014 | Dec 31, 2012 | $38.74B | Feb 18, 2015 |
| FY2013 | Dec 31, 2011 | $36.47B | Feb 19, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.21B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.49B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.81B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.93B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $3.37B | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | $512.00M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $689.00M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $940.00M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $566.00M | Feb 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.70B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.56B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $4.01B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.80B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.15B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $4.99B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $3.19B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $3.10B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $4.26B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.74B | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.45B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $13.70B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $13.19B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $12.67B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $10.12B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $10.05B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $7.38B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $7.53B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $6.57B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $7.17B | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $921.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.97B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.98B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $4.59B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.26B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $5.64B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $5.28B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $2.17B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $4.05B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.94B | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $546.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $575.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.00B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.14B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.34B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $964.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $736.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $612.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $524.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $527.00M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.91B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $46.48B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $47.07B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $43.06B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $44.36B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $34.97B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $29.07B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $25.41B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $27.18B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $25.40B | Feb 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.17B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $30.03B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $30.75B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $27.69B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $28.26B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $21.24B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $17.04B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $15.25B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $17.34B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $14.71B | Feb 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.66B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $16.38B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $16.26B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $15.31B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $16.08B | Feb 16, 2023 |
| FY2020 | Dec 31, 2020 | $13.73B | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $12.04B | Feb 18, 2021 |
| FY2020 | Dec 31, 2018 | $10.16B | Feb 18, 2021 |
| FY2020 | Dec 31, 2017 | $9.84B | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | $10.69B | Feb 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.69B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $9.63B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $9.55B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $9.14B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $11.09B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $4.45B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $3.93B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $3.90B | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $3.28B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $3.27B | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.08B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $28.32B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $27.54B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $25.49B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $23.09B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $20.52B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $17.48B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $15.07B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $13.67B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $11.45B | Feb 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.20B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.22B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $4.69B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $5.06B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $3.39B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.67B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $4.05B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $2.34B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $4.04B | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $3.88B | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $2.60B | Feb 19, 2014 |
| FY2012 | Dec 31, 2012 | $2.61B | Feb 22, 2013 |
| FY2011 | Dec 31, 2011 | $1.66B | Feb 24, 2012 |
| FY2010 | Dec 31, 2010 | $1.67B | Feb 18, 2011 |
| FY2010 | Dec 31, 2009 | $1.68B | Feb 18, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 10 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 20 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 22 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 22 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 25 | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | 3 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 5 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 6 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | 4 | Feb 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 9 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 20 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 22 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 22 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 25 | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | 3 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 5 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 6 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | 4 | Feb 20, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $98.00M | Feb 16, 2023 |
| FY2021 | Dec 31, 2021 | $90.00M | Feb 17, 2022 |